Working… Menu

A Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03976401
Recruitment Status : Active, not recruiting
First Posted : June 6, 2019
Last Update Posted : April 26, 2021
Information provided by (Responsible Party):
Akero Therapeutics, Inc

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : February 10, 2021
Estimated Study Completion Date : August 2021